Leslie Samuel

University of Aberdeen

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (24)

James Glasbey

University of Birmingham

UNITED KINGDOM

View details

Maxime Lafarge

University of Basel

SWITZERLAND

View details

Enric Domingo

University of Oxford

UNITED KINGDOM

View details

Nicholas West

University of Leeds School of Medicine

UNITED KINGDOM

View details

Matthew Seymour

Professor of Gastrointestinal Cancer Medicine

University of Leeds

UNITED KINGDOM

View details

Séan Micheal O'Cathail

University of Glasgow

UNITED KINGDOM

View details

David J. Fisher

UNITED KINGDOM

View details

David Lurie

University of Aberdeen

UNITED KINGDOM

View details

XUEDAN WANG

University of Oxford

UNITED KINGDOM

View details

Philip Dunne

Reader in Molecular Pathology and Early Detection

UNITED KINGDOM

View details

Ultan McDermott

Chief Scientist

AstraZeneca UK Limited

UNITED KINGDOM

View details

Louise Locock

University of Aberdeen

UNITED KINGDOM

View details

Richard Adams

Professor

Cardiff University

UNITED KINGDOM

View details

Viktor Koelzer

University of Zurich

SWITZERLAND

View details

Louise Brown

University College London

UNITED KINGDOM

View details

Peter Murchie

University of Aberdeen

UNITED KINGDOM

View details

Timothy Stanley Maughan

Professor of Clinical Oncology, CRUK/MRC Oxford Institute for Radiation Oncology

University of Oxford

UNITED KINGDOM

View details

Lisa Duncan

University of Aberdeen

UNITED KINGDOM

View details

Simon Bach

University of Birmingham

UNITED KINGDOM

View details

Anne Kiltie

University of Aberdeen

UNITED KINGDOM

View details

Sara MacLennan

University of Aberdeen

UNITED KINGDOM

View details

Danuta Kruk

University of Warmia and Mazury in Olsztyn

POLAND

View details

David Sebag-Montefiore

Professor of Clinical Oncology and Health Research

University of Leeds

UNITED KINGDOM

View details

Catherine Hanna

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Leslie Samuel

Research Interests

Explore related searches

Contact this professor

Articles (20)

Co-design of the Structured Personalised Assessment for Reviews after Cancer (SPARC) Intervention

Tumour purity assessment with deep learning in colorectal cancer and impact on molecular analysis

Dietary fibre supplementation enhances radiotherapy tumour control and alleviates intestinal radiation toxicity

Risk of bowel obstruction in patients with colon cancer responding to immunotherapy: an international case series

Stratification to Neoadjuvant Radiotherapy in Rectal Cancer by Regimen and Transcriptional Signatures

Identification and validation of a machine learning model of complete response to radiation in rectal cancer reveals immune infiltrate and TGFβ as key predictors.

Image-based consensus molecular subtyping in rectal cancer biopsies and response to neoadjuvant chemoradiotherapy

Markers of low field NMR relaxation features of tissues

Exploratory biomarker analysis for predicting treatment effects of aflibercept in the VELOUR trial.

P-164 Efficacy and safety of dostarlimab in UK-specific patients with mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H) or DNA polymerase epsilon, catalytic subunit (POLƐ)-mutated solid tumours in the GARNET study

Treatment Exposure-Adjusted Event Rates (EAERs) for Grade 3/4 AEs Associated with Emerging and Existing Systemic Therapies for mCRC with at Least 2 Prior Lines of Therapy: Informing Payer and Pathway Formulary Decision Making

Experiences of running a stratified medicine adaptive platform trial: Challenges and lessons learned from 10 years of the FOCUS4 trial in metastatic colorectal cancer

Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177)

Oral antibiotic use and early-onset colorectal cancer: findings from a case-control study using a national clinical database

Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning

Correction to: Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT)

Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT)

Capecitabine Versus Active Monitoring in Stable or Responding Metastatic Colorectal Cancer After 16 Weeks of First-Line Therapy: Results of the Randomized FOCUS4-N Trial

Case Report

Pathological response post neoadjuvant therapy for locally advanced rectal cancer is an independent predictor of survival

Collaborators (24)

James Glasbey

Maxime Lafarge

Enric Domingo

Nicholas West

Matthew Seymour

Séan Micheal O'Cathail

David J. Fisher

David Lurie

XUEDAN WANG

Philip Dunne

Ultan McDermott

Louise Locock

Richard Adams

Viktor Koelzer

Louise Brown

Peter Murchie

Timothy Stanley Maughan

Lisa Duncan

Simon Bach

Anne Kiltie

Sara MacLennan

Danuta Kruk

David Sebag-Montefiore

Catherine Hanna

Make your next move.